Pathstone Family Office, LLC Charles River Laboratories International, Inc. Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
A detailed history of Pathstone Family Office, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 3,082 shares of CRL stock, worth $504,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,082
Previous 2,425
27.09%
Holding current value
$504,800
Previous $509,000
18.66%
% of portfolio
0.0%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
51.8MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$999 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$833 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$613 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$349 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$318 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.33B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...